FDA ANDA · ANDA201899

RASAGILINE MESYLATE

Sponsor: ALKEM LABS LTD

APPLICATION

ANDA201899

TYPE

ANDA

ROUTE

ORAL

DOSAGE FORM

TABLET

MARKETING STATUS

None (Tentative Approval)

Products

RASAGILINE MESYLATENone (Tentative Approval)

RASAGILINE MESYLATE EQ 0.5MG BASE · TABLET · ORAL

RASAGILINE MESYLATENone (Tentative Approval)

RASAGILINE MESYLATE EQ 1MG BASE · TABLET · ORAL

2015-05-21OriginalTA

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.